Raucy J L, Lasker J M, Kraner J C, Salazar D E, Lieber C S, Corcoran G B
University of New Mexico, Toxicology Program, College of Pharmacy, Albuquerque 87131.
Mol Pharmacol. 1991 Mar;39(3):275-80.
Cytochrome P450IIE1 (IIE1) is a microsomal xenobiotic-activating enzyme that is inducible not only by various chemical agents but also by fasting and diabetes. Using a rat model that mimics human obesity, we have found that hepatic IIE1 levels are also increased by this common clinical disorder. Liver microsomes from rats made obese by feeding with an energy-dense diet displayed elevated aggregate P450 content (+28%) and enhanced catalytic activities associated with IIE1, including low-Km N-nitrosodimethylamine demethylation (+66%), aniline hydroxylation (+52%), p-nitrophenol hydroxylation (+170%), and acetaminophen-cysteine conjugate formation (+28%). In contrast, obesity had no significant effect on cytochrome b5 content, P450 reductase activity, benzphetamine demethylation, or erythromycin demethylation, with the latter two reactions being linked with rat IIC11 and IIIA1, respectively. The enhancement of IIE1-dependent drug-metabolizing activities noted in liver microsomes from obese rats was paralleled by a similar increase (111%) in hepatic IIE1 protein content in these animals, as assessed on immunoblots developed with anti-hamster IIE1 IgG. Anti-IIE1-inhibitable rates of microsomal p-nitrophenol metabolism, a reaction highly correlated with IIE1 content (r = 0.88, p less than 0.01), were over 3-fold higher in obese rats than in nonobese controls, providing additional evidence for the obesity-related increase of hepatic IIE1. The induction of IIE1 by the pathophysiological condition of obesity may provide a biochemical basis for the increased incidence of occult liver disease and certain cancers noted in obese individuals.
细胞色素P450IIE1(IIE1)是一种微粒体异生物激活酶,不仅可被各种化学试剂诱导,还可被禁食和糖尿病诱导。使用模拟人类肥胖的大鼠模型,我们发现这种常见的临床病症也会使肝脏IIE1水平升高。用高热量饮食喂养致肥胖的大鼠肝脏微粒体显示,总P450含量升高(+28%),与IIE1相关的催化活性增强,包括低Km N-亚硝基二甲胺去甲基化(+66%)、苯胺羟基化(+52%)、对硝基苯酚羟基化(+170%)和对乙酰氨基酚-半胱氨酸结合物形成(+28%)。相比之下,肥胖对细胞色素b5含量、P450还原酶活性、苄非他明去甲基化或红霉素去甲基化无显著影响,后两个反应分别与大鼠IIC11和IIIA1相关。肥胖大鼠肝脏微粒体中IIE1依赖性药物代谢活性的增强与这些动物肝脏IIE1蛋白含量的类似增加(111%)平行,这是在用抗仓鼠IIE1 IgG显影的免疫印迹上评估得出的。微粒体对硝基苯酚代谢的抗IIE1抑制率在肥胖大鼠中比非肥胖对照高3倍以上,该反应与IIE1含量高度相关(r = 0.88,p < 0.01),为肥胖相关的肝脏IIE1增加提供了额外证据。肥胖的病理生理状况对IIE1的诱导可能为肥胖个体中隐匿性肝病和某些癌症发病率增加提供生化基础。